Current utilisation of advanced techniques and technologies in palliative radiation therapy in Australia and New Zealand.

IF 2.2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Pavthrun Pathmanathan, Daniel Roos, Kathy Pope, Melissa L James, Minjae Lah, Chris M Frampton
{"title":"Current utilisation of advanced techniques and technologies in palliative radiation therapy in Australia and New Zealand.","authors":"Pavthrun Pathmanathan, Daniel Roos, Kathy Pope, Melissa L James, Minjae Lah, Chris M Frampton","doi":"10.1111/1754-9485.13805","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The techniques employed in palliative radiation therapy are highly variable, ranging from basic (2D/3D-conformal) to more advanced (beam modulation and stereotactic techniques), and their relative use has not previously been formally investigated at a national level. The purpose of this work was to assess the current utilisation of palliative techniques and technologies in Australia and New Zealand (ANZ).</p><p><strong>Methods: </strong>A voluntary, anonymous, internet-based, RANZCR approved survey was offered to all practising radiation oncology (RO) Fellows in ANZ. Participants selected their preferred methods of managing patients in five case studies involving bone, brain, lung metastases and locally advanced lung cancer.</p><p><strong>Results: </strong>From October 2022 to February 2023, 146 of 485 eligible participants (30%) responded. In all, 61% and 81% would treat an uncomplicated breast cancer solitary spinal metastasis with stereotactic body radiation therapy routinely and ideally, respectively; 11% and 32% would treat a solitary lung cancer brain metastasis with dedicated stereotactic radiosurgery routinely and ideally; 36% and 56% would treat multiple low-volume brain metastases with a stereotactic technique routinely and ideally. There was negligible difference in the routine and preferred use of advanced technologies for a solitary bowel cancer lung metastasis; 69% and 77% would treat a locally advanced primary lung cancer with an advanced technique routinely and ideally. Relative to Australia, NZ ROs routinely treat uncomplicated solitary spinal metastases (P < 0.001), solitary brain metastases (P < 0.001), multiple low-volume brain metastases (P < 0.02), and locally advanced primary lung cancer (P < 0.001) more commonly with basic technologies, mainly due to limited local availability of advanced technology and departmental waiting lists.</p><p><strong>Conclusion: </strong>Participants generally favoured treating with advanced techniques and technologies in palliative settings, if available, but there were notable disparities between the two countries. Enhanced local access and clinical training may facilitate optimal utilisation of advanced technologies and improve clinical outcomes.</p>","PeriodicalId":16218,"journal":{"name":"Journal of Medical Imaging and Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Imaging and Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1754-9485.13805","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The techniques employed in palliative radiation therapy are highly variable, ranging from basic (2D/3D-conformal) to more advanced (beam modulation and stereotactic techniques), and their relative use has not previously been formally investigated at a national level. The purpose of this work was to assess the current utilisation of palliative techniques and technologies in Australia and New Zealand (ANZ).

Methods: A voluntary, anonymous, internet-based, RANZCR approved survey was offered to all practising radiation oncology (RO) Fellows in ANZ. Participants selected their preferred methods of managing patients in five case studies involving bone, brain, lung metastases and locally advanced lung cancer.

Results: From October 2022 to February 2023, 146 of 485 eligible participants (30%) responded. In all, 61% and 81% would treat an uncomplicated breast cancer solitary spinal metastasis with stereotactic body radiation therapy routinely and ideally, respectively; 11% and 32% would treat a solitary lung cancer brain metastasis with dedicated stereotactic radiosurgery routinely and ideally; 36% and 56% would treat multiple low-volume brain metastases with a stereotactic technique routinely and ideally. There was negligible difference in the routine and preferred use of advanced technologies for a solitary bowel cancer lung metastasis; 69% and 77% would treat a locally advanced primary lung cancer with an advanced technique routinely and ideally. Relative to Australia, NZ ROs routinely treat uncomplicated solitary spinal metastases (P < 0.001), solitary brain metastases (P < 0.001), multiple low-volume brain metastases (P < 0.02), and locally advanced primary lung cancer (P < 0.001) more commonly with basic technologies, mainly due to limited local availability of advanced technology and departmental waiting lists.

Conclusion: Participants generally favoured treating with advanced techniques and technologies in palliative settings, if available, but there were notable disparities between the two countries. Enhanced local access and clinical training may facilitate optimal utilisation of advanced technologies and improve clinical outcomes.

澳大利亚和新西兰目前在姑息放射治疗中使用的先进技术。
简介姑息放射治疗所采用的技术千差万别,从最基本的(2D/3D-适形)到更先进的(射束调制和立体定向技术)不等,而这些技术的相对使用情况此前尚未在全国范围内进行过正式调查。这项工作的目的是评估目前澳大利亚和新西兰(ANZ)姑息治疗技术的使用情况:方法:向澳大利亚和新西兰(ANZ)的所有放射肿瘤学(RO)执业研究员提供一项自愿、匿名、基于互联网、经 RANZCR 批准的调查。参与者在涉及骨癌、脑癌、肺转移癌和局部晚期肺癌的五个病例研究中选择了他们喜欢的治疗方法:从 2022 年 10 月到 2023 年 2 月,485 名符合条件的参与者中有 146 人(30%)做出了回应。在所有参与者中,61%和81%的人在常规和理想情况下分别会采用立体定向体部放疗治疗无并发症的乳腺癌单发脊柱转移瘤;11%和32%的人在常规和理想情况下分别会采用专用立体定向放射外科治疗单发肺癌脑转移瘤;36%和56%的人在常规和理想情况下分别会采用立体定向技术治疗多发低体积脑转移瘤。对于单发肠癌肺转移灶,常规和首选使用先进技术的差异微乎其微;69% 和 77% 的人在常规和理想情况下会使用先进技术治疗局部晚期原发性肺癌。与澳大利亚相比,新西兰的研究人员常规治疗无并发症的单发脊柱转移瘤(P 结论):与会者普遍赞成在姑息治疗中采用先进的技术和疗法,但两国之间存在明显差异。加强当地就医和临床培训可促进先进技术的最佳利用并改善临床疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.30
自引率
6.20%
发文量
133
审稿时长
6-12 weeks
期刊介绍: Journal of Medical Imaging and Radiation Oncology (formerly Australasian Radiology) is the official journal of The Royal Australian and New Zealand College of Radiologists, publishing articles of scientific excellence in radiology and radiation oncology. Manuscripts are judged on the basis of their contribution of original data and ideas or interpretation. All articles are peer reviewed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信